Paul Peter Tak

Chief Executive Officer, Director, Candel Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$3.2M

Companies

Latest trade

Sep 11, 2026

Companies

Candel Therapeutics, Inc.Chief Executive Officer, Director −$3.2M

Trades

CADL Sold 59,379 shares at $10.46 · planned $0.6M Sep 11

CADL Sold 220,866 shares at $11.50 · planned $2.5M Sep 10

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.